Rekah Pharmaceutical (Israel) Market Value
| REKA Stock | ILA 1,499 110.00 7.92% |
| Symbol | Rekah |
Rekah Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rekah Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rekah Pharmaceutical.
| 02/09/2023 |
| 11/30/2024 |
If you would invest 0.00 in Rekah Pharmaceutical on February 9, 2023 and sell it all today you would earn a total of 0.00 from holding Rekah Pharmaceutical Industry or generate 0.0% return on investment in Rekah Pharmaceutical over 660 days. Rekah Pharmaceutical is related to or competes with Bezeq Israeli, Brainsway, Mivne Real, Photomyne, and Israel Land. Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC... More
Rekah Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rekah Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rekah Pharmaceutical Industry upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.74 | |||
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 16.72 | |||
| Value At Risk | (5.51) | |||
| Potential Upside | 6.89 |
Rekah Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rekah Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rekah Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Rekah Pharmaceutical historical prices to predict the future Rekah Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0087 | |||
| Jensen Alpha | 0.0243 | |||
| Total Risk Alpha | (0.61) | |||
| Sortino Ratio | (0.04) | |||
| Treynor Ratio | 0.0263 |
Rekah Pharmaceutical Backtested Returns
At this point, Rekah Pharmaceutical is very steady. Rekah Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of 0.0324, which implies the firm had a 0.0324% return per unit of risk over the last 3 months. We have found thirty technical indicators for Rekah Pharmaceutical, which you can use to evaluate the volatility of the company. Please check Rekah Pharmaceutical's Coefficient Of Variation of 97835.84, semi deviation of 3.46, and Risk Adjusted Performance of 0.0087 to confirm if the risk estimate we provide is consistent with the expected return of 0.11%. Rekah Pharmaceutical has a performance score of 2 on a scale of 0 to 100. The company holds a Beta of -0.24, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Rekah Pharmaceutical are expected to decrease at a much lower rate. During the bear market, Rekah Pharmaceutical is likely to outperform the market. Rekah Pharmaceutical right now holds a risk of 3.54%. Please check Rekah Pharmaceutical total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to decide if Rekah Pharmaceutical will be following its historical price patterns.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Rekah Pharmaceutical Industry has insignificant reverse predictability. Overlapping area represents the amount of predictability between Rekah Pharmaceutical time series from 9th of February 2023 to 5th of January 2024 and 5th of January 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rekah Pharmaceutical price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Rekah Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 7876.89 |
Rekah Pharmaceutical lagged returns against current returns
Autocorrelation, which is Rekah Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rekah Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Rekah Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Rekah Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Rekah Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rekah Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rekah Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rekah Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
Rekah Pharmaceutical Lagged Returns
When evaluating Rekah Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rekah Pharmaceutical stock have on its future price. Rekah Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rekah Pharmaceutical autocorrelation shows the relationship between Rekah Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Rekah Pharmaceutical Industry.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Rekah Stock
Rekah Pharmaceutical financial ratios help investors to determine whether Rekah Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rekah with respect to the benefits of owning Rekah Pharmaceutical security.